Type 1 diabetes (T1D) is driven by autoreactive CD4+ T-cell responses to pancreatic beta cell antigens presented by disease-associated human leucocyte antigen (HLA) class II molecules. However, the molecular mechanisms by which subtle antigenic modifications promote pathogenic immunity remain incompletely defined. Recent immunopeptidomic studies have identified a cysteine-to-serine substitution at position 19 of the insulin B chain, referred to as InsC19S, as a microenvironment-driven neoepitope that can be presented by HLA class II molecules, including HLA-DQ8, and is recognized by diabetogenic CD4+ T cells. In this study we explore potential structural and thermodynamic mechanisms that may contribute to the enhanced immunogenicity associated with this single-amino-acid modification. Using molecular dynamics simulations combined with coarse-grained free-energy-perturbation analyses, we compared HLA DQ8 complexes bound to wild-type (WT) insulin and InsC19S peptides. The InsC19S variant is predicted in simulations to exhibit enhanced binding stability, characterized by increased hydrogen bond occupancy, reduced peptide conformational mobility, and a more favorable binding free energy. In addition, the modified peptide is predicted to induce peptide-dependent conformational adjustments within the HLA-DQ8 peptide-binding groove, resulting in expansion of the conformational landscape and stabilization of distinct low-energy states that are not accessed by the WT complex. Principal component analysis and free-energy landscape mapping suggest that this mutation may promote altered collective motions within HLA DQ8 that are consistent with enhanced peptide major histocompatibility complex (MHC) persistence and optimized antigen presentation geometry. Together, these computational observations suggest a structural framework that may help explain the preferential presentation and pathogenic recognition of InsC19S reported in experimental studies. These findings provide a molecular-level framework that may help link microenvironment-driven insulin neoepitope formation to altered peptide–MHC stability and conformational dynamics in HLA-DQ8.
Lasso peptides are a class of ribosomally synthesized and post-translationally modified peptides (RiPPs) where the C-terminal tail is threaded and sterically trapped within an N-terminal macrolactam ring. In the present work, the thermal unthreading process of the lasso peptide syanodin I was characterized using liquid chromatography, trapped ion mobility spectrometry, electron-capture dissociation, and tandem mass spectrometry (LC-TIMS-q-ECD-ToF MS/MS) and steered molecular dynamics (SMD). The analytical workflow allows for the separation (LC and TIMS) and identification (ECD MS/MS) of syanodin I kinetic intermediates as a function of the solution temperature. The syanodin WT with the plug residue Gln13 can be identified from the branched-cyclic topology based on unique retention time (RT), IMS bands, and hydrogen migration events near the molecular knot (ci•/zj′ fragments). After heat treatment for 1 h at 95 °C, the unthreaded syanodin I (branched-cyclic) and an intermediate lasso structure, with Leu15 as plug residue, are identified based on the RT, IMS bands and signature ECD MS/MS fragments. Mutagenesis experiments, substituting to bulkier ([L15W] and [L15W/A16W]) and smaller ([L15A]) residues, confirmed the intermediate plug residue at Leu15. Changes in the initial plug residue Gln13 to a smaller residue ([Q13A]) resulted in a lasso structure with Leu15 as the plug residue. SMD simulations supported a loop-pulling mechanism, but also the possibility of a tail-pulling mechanism, in good agreement with the experimental observations. This is the first report of a two-step, lasso thermal unfolding mechanism driven by the two steric constraints based on loop-pulling of the lasso tail.
The Ebola virus (EBOV) has been responsible for several outbreaks in Africa over the last decade causing severe hemorrhagic fever with limited treatment options. EBOV is a lipid-enveloped filamentous negative-sense RNA virus with a genome encoding seven proteins. This includes the matrix protein VP40, which regulates assembly and budding of new virions from the inner leaflet of the host cell plasma membrane (PM). VP40 is a multifaceted protein that has different oligomeric states to regulate different parts of the virus life cycle. We investigated how two patient-derived mutations of VP40 samples (R204H and H269R) altered VP40 electrostatics, VP40 oligomeric state, interactions with PM anionic lipids and how these changes affect virus-like particle formation using both laboratory and computational approaches. The R204H mutation induced exclusive octamer formation destabilizing the dimer structure needed for proper lipid binding, PM localization, and virus-like particle formation. In contrast, H269R altered VP40 C-terminal domain (CTD) electrostatics and had similar dimer formation to WT VP40. H269R led to an increase in PM localization compared to WT VP40 and had a three-fold increase in affinity for PM anionic lipids (phosphatidylserine and PI(4,5)P2), consistent with the increased PM localization. Molecular dynamics simulations revealed increased interactions of H269R with phosphatidylserine by several CTD residues. These results highlight the properties of two electrostatic changes found in nature on VP40 structure and function. Understanding the effects of amino acid substitutions on VP40 biophysical properties will be helpful in explaining changes in EBOV variants that occur in nature.
29 April 2025 in The Journal of Physical Chemistry B